Is Gritstone Bio Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: GRTS) stock is to Strong Buy GRTS stock.
Out of 2 analysts, 1 (50%) are recommending GRTS as a Strong Buy, 1 (50%) are recommending GRTS as a Buy, 0 (0%) are recommending GRTS as a Hold, 0 (0%) are recommending GRTS as a Sell, and 0 (0%) are recommending GRTS as a Strong Sell.
What is GRTS's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: GRTS) forecast ROE is N/A, which is considered weak.
What is GRTS's Price Target?
According to 2 Wall Street analysts that have issued a 1 year GRTS price target, the average GRTS price target is $7.50, with the highest GRTS stock price forecast at $8.00 and the lowest GRTS stock price forecast at $7.00.
On average, Wall Street analysts predict that Gritstone Bio's share price could reach $7.50 by Aug 10, 2024. The average Gritstone Bio stock price prediction forecasts a potential upside of 525% from the current GRTS share price of $1.20.
What is GRTS's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: GRTS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.1%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.